Immunotherapies in oncology have been touted as exciting new breakthroughs in cancer treatment, but do they deliver on the promise? In this episode, we’ll review disappointing results from two clinical trials in the cancer immunotherapy space reported in July 2017. We’ll also hear from physicians at ASCO 2016 on the first line role of immunotherapy, as well as challenges of using these agents.